Table 3. Laboratory methods used for determination of possible senescent-cell biomarkers.
Analyte | Method | References |
---|---|---|
morphological analysis | inverted phase-contrast microscope | 73 |
cell viability | tetrazolium reduction, microplate spectrophotometer | 71 |
SASP | ELISA | 12,68 |
SAHF | immunohistochemistry | 12 |
γH2AX | histochemistry | 12,68 |
p16, p53, and p21 | histochemistry, immunohistochemistry | 12 |
SA‐β‐GAL | histochemistry, immunohistochemistry, flow cytometry | 12,68,79 |
autophagy | immunoblotting | 72 |
cell proliferation | flow cytometry | 73 |
leukocyte absolute telomere length | southern blot, PCR, FISH | 68,75,76 |
ELISA – enzyme linked immunosorbent assay. SASP – senescence-associated secretory phenotype. SAHF – senescence-associated heterochromatin foci. γH2AX – a type of histone protein from the H2A family, a marker for activation of DNA damage response. PCR – polymerase chain reaction. p16 – cyclin-dependent kinase inhibitor 2A, multiple tumor suppressor 1. p53 – tumour suppressor gene, induces senescence growth arrest via activated p21–p53 pathway. p21– cell-cycle inhibitor, induces senescence growth arrest via activated p21–p53 pathway. SA‐β‐GAL – senescence-associated β-galactosidase. FISH – fluorescent in situ hybridization. |